16 Results for "

SMAC mimetic

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "SMAC mimetic" in MCE Product Catalog:

61
61 Publications Verification
Cat. No.: HY-15989
CAS No.: 957135-43-2
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-164 is a cell-permeable Smac mimetic compound. SM-164 binds to XIAP protein containing both the BIR2 and BIR3 domains with an IC50 value of 1.39 nM and functions as an extremely potent antagonist of XIAP.
loading...
    loading...
61
61 Publications Verification
Cat. No.: HY-15989A
CAS No.: 2734174-02-6
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-164 hydrochloride is a cell-permeable Smac mimetic compound. SM-164 binds to XIAP protein containing both the BIR2 and BIR3 domains with an IC50 value of 1.39 nM and functions as an extremely potent antagonist of XIAP.
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-16591
CAS No.: 1260251-31-7
Synonyms: TL32711
Target:  

IAP Apoptosis HIV

Research Areas:  

Cancer

Birinapant (TL32711), a bivalent Smac mimetic, is a potent antagonist for XIAP and cIAP1 with Kds of 45 nM and less than 1 nM, respectively. Birinapant (TL32711) induces the autoubiquitylation and proteasomal degradation of cIAP1 and cIAP2 in intact cells, which results in formation of a RIPK1: caspase-8 complex, caspase-8 activation, and induction of tumor cell death. Birinapant (TL32711) targets TRAF2-associated cIAPs and abrogates TNF-induced NF-κB activation.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15454
CAS No.: 1071992-99-8
Purity:  99.91%
Synonyms: AT-406; Debio 1143; SM-406
Target:  

IAP Apoptosis

Research Areas:  

Cancer

Xevinapant (AT-406) is a potent and orally bioavailable Smac mimetic and an antagonist of IAPs, and it binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, respectively.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-13208
CAS No.: 1071992-57-8
Purity:  98.01%
Synonyms: AT-406 hydrochloride; Debio 1143 hydrochloride; SM-406 hydrochloride
Target:  

IAP Apoptosis

Research Areas:  

Cancer

Xevinapant (AT-406) hydrochloride is a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs). Xevinapant hydrochloride binds to XIAP, cIAP1, and cIAP2 proteins with Kis of 66.4, 1.9, and 5.1 nM, respectively. Xevinapant hydrochloride effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degradation of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines. Xevinapant hydrochloride is highly effective in induction of apoptosis in xenograft tumors .
loading...
    loading...
Cat. No.: HY-125593
CAS No.: 1570231-89-8
Purity:  99.36%
Synonyms: APG-1387
Target:  

IAP Apoptosis

Research Areas:  

Cancer

Dasminapant (APG-1387), a bivalent SMAC mimetic and an IAP antagonist, blocks the activity of IAPs family proteins (XIAP, cIAP-1, cIAP-2, and ML-IAP). Dasminapant induces degradation of cIAP-1 and XIAP proteins, as well as caspase-3 activation and PARP cleavage, which leads to apoptosis. Dasminapant can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma .
loading...
    loading...
Cat. No.: HY-125378
CAS No.: 1422180-49-1
Purity:  98.42%
Synonyms: SBI-0636457; SB1-0636457
Target:  

IAP

Research Areas:  

Cancer

SBP-0636457 (SB1-0636457) is a SMAC mimetic, and as an IAP antagonist. SBP-0636457 binds to the BIR-domains of the IAP proteins, with a Ki of 0.27 μM. SBP-0636457 can be used for the research of solid tumors and hematologic cancers .
loading...
    loading...
Cat. No.: HY-15519
CAS No.: 867324-12-7
Target:  

IAP FLT3

Research Areas:  

Cancer

LBW242, a 3-mer and Smac mimetic, is a potent and orally active proapoptotic IAP inhibitor. LBW242 shows effects on mutant FLT3-expressing cells. LBW242 has activity against multiple myeloma, and potentiates TRAIL- and anticancer agent-mediated cell death of ovarian cancer cells .
loading...
    loading...
Cat. No.: HY-125378A
CAS No.: 1422180-61-7
Purity:  98.36%
Synonyms: (7R)-SBI-0636457; (7R)-SB1-0636457
Target:  

IAP

Research Areas:  

Cancer

(7R)-SBP-0636457 is the isomer of SBP-0636457 (HY-125378), and can be used as an experimental control. SBP-0636457 (SB1-0636457) is a SMAC mimetic, and as an IAP antagonist. SBP-0636457 binds to the BIR-domains of the IAP proteins, with a Ki of 0.27 μM. SBP-0636457 can be used for the research of solid tumors and hematologic cancers .
loading...
    loading...
Cat. No.: HY-120434
CAS No.: 949963-04-6
Synonyms: HGS1029
Target:  

IAP

Research Areas:  

Cancer

AEG40826 (HGS1029), a second mitochondria-derived activator of caspases (SMAC) mimetic, is an inhibitor of apoptosis (IAP) inhibitor. AEG40826 degrades cellular IAP1 (cIAP1) and blocks TNF-α pro-survival signaling. AEG40826 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-138059
CAS No.: 1071992-81-8
Purity:  98.83%
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-433, a Smac mimetic, function as inhibitor of inhibitor of apoptosis proteins (IAPs). SM-433 exhibits strong binding affinity XIAP BIR3 protein with an IC50<1 μM (patent WO2008128171A2) .
loading...
    loading...
Cat. No.: HY-155294
CAS No.: 874270-38-9
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-122 is a monovalent Smac mimetic targeting cellular inhibitor of apoptosis protein (cIAP)-1/2. SM-122 can induce cIAP-1/2 degradation and weakly induce apoptosis in tumor cells. SM-122 can be used for the research of cancer, such as breast cancer .
loading...
    loading...
Cat. No.: HY-138059A
Purity:  98.57%
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-433 hydrochlorid, a Smac mimetic, function as inhibitor of inhibitor of apoptosis proteins (IAPs). SM-433 hydrochlorid exhibits strong binding affinity XIAP BIR3 protein with an IC50<1 μM (patent WO2008128171A2) .
loading...
    loading...
Cat. No.: HY-181532
Research Areas:  

Cancer

IAP ligand 8 is an ASX-series, non-peptidic SMAC mimetic and IAP binder with high cell permeability. IAP ligand 8 selectively targets cIAP1-BIR3, XIAP-BIR2 (with a KD of 15.8 nM for both). IAP ligand 8 serves as an IAP ligand moiety to synthesize IAP-recruiting protein degrader (IPD) (HY-181590). This IPD simultaneously forms two ternary complexes, cIAP1-A538-TEAD1 and XIAP-A538-TEAD1, and efficiently degrades TEAD1 via a dual E3 recruitment mechanism, while inducing the autodegradation of cIAP1. IAP ligand 8 and its series of degraders are applicable to targeted research on Hippo pathway-dysregulated cancers such as NF2-mutant mesothelioma .
loading...
    loading...
Cat. No.: HY-181533
Research Areas:  

Cancer

IAP ligand 9 is an ASX-series, non-peptidic SMAC mimetic and IAP binder with high cell permeability. IAP ligand 9 selectively targets cIAP1-BIR3, XIAP-BIR3, exhibits extremely weak binding affinity for XIAP-BIR2, with a KD of 100 nM for cIAP1-BIR3 and 10 nM for XIAP-BIR2. IAP ligand 9 can be used to synthesize IAP-recruiting protein degraders (IPD), and can calibrate the cell permeability and cellular-level target binding assays of the IPD molecule SNIPER (TEAD)-1 (HY-181607). IAP ligand 9 and its series of degraders can be used in the research of solid tumors such as malignant pleural mesothelioma associated with abnormal activation of the Hippo pathway .
loading...
    loading...
Cat. No.: HY-181530
Research Areas:  

Cancer

IAP ligand 6 (A250) is an IAP ligand that can be used for the synthesis of PROTACs, such as PROTAC TEAD1/IAP degrader-1 (HY-181534) .
loading...
    loading...
  • 1